These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10319064)

  • 1. Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.
    Telenti A
    Thorax; 1998 Sep; 53(9):793-7. PubMed ID: 10319064
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogen-based precision medicine for drug-resistant tuberculosis.
    Gröschel MI; Walker TM; van der Werf TS; Lange C; Niemann S; Merker M
    PLoS Pathog; 2018 Oct; 14(10):e1007297. PubMed ID: 30335850
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular analysis of drug resistant TB.
    Melzer M; Brown TJ; French GL; Dickens A; McHugh TD; Bagg LR; Storring RA; Lacey S
    Thorax; 2002 Jun; 57(6):562-3. PubMed ID: 12037237
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug resistant tuberculosis.
    Amdekar YK
    Indian Pediatr; 1998 Aug; 35(8):715-8. PubMed ID: 10216564
    [No Abstract]   [Full Text] [Related]  

  • 6. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level.
    Velayati AA; Farnia P; Masjedi MR; Ibrahim TA; Tabarsi P; Haroun RZ; Kuan HO; Ghanavi J; Farnia P; Varahram M
    Eur Respir J; 2009 Nov; 34(5):1202-3. PubMed ID: 19880622
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Mnyambwa NP; Kim DJ; Ngadaya ES; Kazwala R; Petrucka P; Mfinanga SG
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2021-2028. PubMed ID: 28593375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
    Prozorov AA; Zaĭchikova MV; Danilenko VN
    Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypic instability of Mycobacterium tuberculosis strains harbouring clinically prevalent drug-resistant mutations.
    Chen Y; Takiff HE; Gao Q
    Lancet Microbe; 2023 May; 4(5):e292. PubMed ID: 36716755
    [No Abstract]   [Full Text] [Related]  

  • 14. Why is long-term therapy required to cure tuberculosis?
    Connolly LE; Edelstein PH; Ramakrishnan L
    PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 16. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
    Schito M; Dolinger DL
    EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
    [No Abstract]   [Full Text] [Related]  

  • 17. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis.
    Gagneux S; Burgos MV; DeRiemer K; Encisco A; Muñoz S; Hopewell PC; Small PM; Pym AS
    PLoS Pathog; 2006 Jun; 2(6):e61. PubMed ID: 16789833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.